文献速递消化道肿瘤与早癌肝病

KIAA1199通过调节中性粒细胞浸润驱动免疫抑制促进结直肠癌肝转移

KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration.
PubMed 文献 · Hepatology · 2022-03-02

该研究探讨KIAA1199在结直肠癌肝转移中的免疫调节作用。在结直肠癌患者中,KIAA1199高表达与肝脏中性粒细胞浸润增加相关,并在小鼠转移模型中验证。KIAA1199通过TGFβ-CXCL3/1-CXCR2轴促进免疫抑制性中性粒细胞聚集,遗传阻断或药物抑制KIAA1199可恢复肿瘤免疫浸润、阻碍肿瘤进展并增强免疫检查点阻断(ICB)疗效。

要点

  • 结直肠癌患者中KIAA1199高表达与肝脏中性粒细胞浸润增加相关。
  • KIAA1199通过TGFβ-CXCL3/1-CXCR2轴驱动免疫抑制性中性粒细胞聚集。
  • 遗传阻断或药物抑制KIAA1199可恢复免疫浸润并增强ICB疗效。

核心结论

  • KIAA1199通过TGFβ-趋化因子(C-X-C基序)配体(CXCL)3/1-CXCR2轴促进免疫抑制性中性粒细胞向肝脏浸润,从而驱动结直肠癌肝转移。
  • 该轴可能成为治疗肝转移的临床靶点。

研究设计与样本

  • 采用流式细胞术检测KIAA1199对肿瘤免疫细胞浸润的影响。
  • 分离中性粒细胞和T细胞,进行刺激和/或培养以开展体外功能实验。
  • 在结直肠癌患者中分析KIAA1199表达与肝脏中性粒细胞浸润的关联,并在小鼠转移模型中验证。

主要发现

  • 在结直肠癌患者中,KIAA1199高表达与肝脏中性粒细胞浸润增加相关。
  • 小鼠转移模型进一步验证了上述结果。
  • 中性粒细胞流入增加促进了KIAA1199驱动的结直肠癌肝转移。
  • KIAA1199通过与TGFBR1/2相互作用激活TGFβ信号通路,刺激CXCL1和CXCL3产生,从而驱动免疫抑制性中性粒细胞聚集。
  • 遗传阻断或药物抑制KIAA1199可恢复肿瘤免疫浸润、阻碍肿瘤进展并增强对免疫检查点阻断(ICB)的应答。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Metastasis is the primary cause of cancer mortality, and colorectal cancer (CRC) frequently metastasizes to the liver. Our previous studies demonstrated the critical role of KIAA1199 in tumor invasion and metastasis in CRC. In the present study, we described an immune regulatory effect of KIAA1199 that creates a permissive environment for metastasis. APPROACH AND RESULTS: Flow cytometry was used to examine the effects of KIAA1199 on the infiltration of tumor immune cells. Neutrophils and T cells were isolated, stimulated, and/or cultured for in vitro function assays. In the patients with CRC, high expression levels of KIAA1199 were associated with an increased neutrophil infiltration into the liver. This result was further validated in mouse metastasis models. The increased influx of neutrophils contributed to the KIAA1199-driven CRC liver metastasis. Mechanistically, KIAA1199 activated the TGFβ signaling pathway by interacting with the TGFBR1/2 to stimulate CXCL1 and CXCL3 production, thereby driving the aggregation of immunosuppressive neutrophils. Genetic blockade or pharmacologic inhibition of KIAA1199 restored tumor immune infiltration, impeded tumor progression, and potentiated response to immune checkpoint blockade (ICB). CONCLUSIONS: These findings indicated that KIAA1199 could facilitate the liver infiltration of immunosuppressive neutrophils via the TGFβ-chemokine (C-X-C motif) ligand (CXCL)3/1-CXCR2 axis, which might be clinically targeted for the treatment of hepatic metastasis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wang H, Zhang B, Li R, et al. KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration. Hepatology. 2022. PMID: 35108400. doi:10.1002/hep.32383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。